Your session is about to expire
← Back to Search
Analgesic
VVZ-149 Injections for Postoperative Pain
Phase 3
Waitlist Available
Research Sponsored by Vivozon, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 0-12 hours post-dose
Awards & highlights
Study Summary
This trial will test how well VVZ-149 Injections work to relieve post-operative pain following bunionectomy, and how safe it is.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 0-12 hours post-dose
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~0-12 hours post-dose
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Time-weighted Sum of Pain Intensity Difference (SPID) from baseline over 12 hours after the start of study drug infusion (i.e., post-dose)
Secondary outcome measures
Proportion of patients who take prescription opioid after discharge
Proportion of patients with >40% improvement in pain from baseline to 6 hours post-dose
Time to onset of perceptible pain relief using the double stopwatch method
+1 moreTrial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: VVZ-149 InjectionsExperimental Treatment1 Intervention
Group II: PlaceboPlacebo Group1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
VVZ-149 Injections
2021
Completed Phase 3
~790
Find a Location
Who is running the clinical trial?
Vivozon, Inc.Lead Sponsor
10 Previous Clinical Trials
702 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger